Skip to main content

Dr. Ming Y. Lim, MB BCHIR

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
19
In the NPI registry since
2009
Medicare patients seen, 2024
69

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2009Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    UT license 10882813-1205 · SC license 37931
  • Hematology (Internal Medicine) Physician
    SC license 37931
  • Internal Medicine Physician
    MN license 54181
  • Student in an Organized Health Care Education/Training Program

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
69
Services billed
125
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes2622
New patient office or other outpatient visit, 60-74 minutes1515
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1414

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Eliquis (apixaban)
Other prescribers in Charleston, SC
32

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 18 payments worth $25,338 in total to this clinician.

By company
E.r. Squibb & Sons, L.l.c.$11,678
Genzyme Corporation$8,406
Hema Biologics, LLC$5,253
By type
Consulting Fee$18,005
Honoraria$4,900
Travel and Lodging$1,943
Food and Beverage$490

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 27, 2025E.r. Squibb & Sons, L.l.c.
Oct 27, 2025
Consulting Fee$10,505
Nov 7, 2025Genzyme Corporation
Nov 7, 2025
Consulting Fee
QFITLIA
$7,500
Mar 12, 2025Hema Biologics, LLC
Mar 12, 2025
Honoraria
SEVENFACT · HEMATOLOGY
$4,900
Oct 4, 2025E.r. Squibb & Sons, L.l.c.
Oct 4, 2025
Travel and Lodging
travel to Anaheim, CA
$808
Nov 7, 2025Genzyme Corporation
Nov 7, 2025
Travel and Lodging
QFITLIA · travel to Dallas, TX · in-kind
$363
Nov 7, 2025Genzyme Corporation
Nov 7, 2025
Travel and Lodging
QFITLIA · travel to Dallas, TX · in-kind
$297
Nov 7, 2025Genzyme Corporation
Nov 7, 2025
Travel and Lodging
QFITLIA · travel to Dallas, TX · in-kind
$246
Oct 4, 2025E.r. Squibb & Sons, L.l.c.
Oct 4, 2025
Travel and Lodging
travel to Anaheim, CA
$201
Mar 7, 2025Hema Biologics, LLC
Mar 7, 2025
Travel and Lodging
SEVENFACT · HEMATOLOGY · travel to SAN DIEGO, CA · in-kind
$14.13
Mar 7, 2025Hema Biologics, LLC
Mar 7, 2025
Travel and Lodging
SEVENFACT · HEMATOLOGY · travel to SAN DIEGO, CA · in-kind
$14.13

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in South Carolina →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $22,729 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Charleston

Sources

NPI registry (CMS NPPES, November 2026; record last updated November 18, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1184855751. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.